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Appropriate excitatory/inhibitory (E/I) balance is essential for normal cortical function and is altered in some psychiatric disorders,
including autism spectrum disorders (ASDs). Cell-autonomousmolecular mechanisms that control the balance of excitatory and inhib-
itory synapse function remain poorly understood; no proteins that regulate excitatory and inhibitory synapse strength in a coordinated
reciprocal manner have been identified. Using super-resolution imaging, electrophysiology, and molecular manipulations, we show that
cadherin-10, encoded by CDH10 within the ASD risk locus 5p14.1, maintains both excitatory and inhibitory synaptic scaffold structure in
cultured cortical neurons from rats of both sexes. Cadherin-10 localizes to both excitatory and inhibitory synapses in neocortex, where it is
organized into nanoscale puncta that influence the size of their associated PSDs. Knockdown of cadherin-10 reduces excitatory but increases
inhibitory synapse size and strength, altering the E/I ratio in cortical neurons. Furthermore, cadherin-10 exhibits differential participation in
complexes with PSD-95 and gephyrin, whichmay underlie its role inmaintaining the E/I ratio. Our data provide a newmechanismwhereby a
protein encoded by a commonASD risk factor controls E/I ratios by regulating excitatory and inhibitory synapses in opposing directions.
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Introduction
The correct balance between excitation and inhibition (E/I bal-
ance) in neuronal circuits of the cerebral cortex is essential for
effective information processing. At the cellular level, this balance
is controlled by the number and strength of excitatory and inhib-
itory inputs. It has been proposed that disruption of synaptic E/I
balance in the cortex underlies the pathology of some neuropsy-
chiatric diseases, including autism spectrum disorders (ASDs;
Gao and Penzes, 2015). To control neuronal excitability, individ-
ual neurons must maintain an appropriate ratio between excit-
atory and inhibitory inputs. Dysfunction of either excitatory or
inhibitory synapses can shift this ratio, leading to pathological
conditions, which suggests the presence of cellular mechanisms to
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Significance Statement
The correct balance between excitatory/inhibitory (E/I) is crucial for normal brain function and is altered in psychiatric disorders
such as autism. However, the molecular mechanisms that underlie this balance remain elusive. To address this, we studied
cadherin-10, an adhesionprotein that is genetically linked to autismandunderstudied at the cellular level. Using a combination of
advanced microscopy techniques and electrophysiology, we show that cadherin-10 forms nanoscale puncta at excitatory and
inhibitory synapses, maintains excitatory and inhibitory synaptic structure, and is essential for maintaining the correct balance
between excitation and inhibition in neuronal dendrites. These findings reveal a new mechanism by which E/I balance is con-
trolled in neurons and may bear relevance to synaptic dysfunction in autism.
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maintain a correct E/I ratio. However, the nature of these putative
cell-autonomous molecular mechanisms that control E/I ratio in
cortical neurons remainmostly unknown.
Numerous rare but highly penetrant point mutations have
implicated synaptic adhesion molecules in controlling E/I bal-
ance. Whereas these rare variants have been extensively investi-
gated (Betancur et al., 2009), they underlie only a small fraction of
autism susceptibility. In contrast, common variants with small
effect sizes have been estimated to account for 50% of autism
susceptibility (Klei et al., 2012; Gaugler et al., 2014), although
their neurobiology is far less studied. The function of common
variants may, therefore, provide crucial insights into ASD patho-
genesis. The first genome-wide association study finding com-
mon variants for ASD revealed strong association signals with
single nucleotide polymorphisms between the genes encoding
cadherin-9 and cadherin-10 (CDH9 and CDH10; Wang et al.,
2009), a finding replicated in additional studies (Ma et al., 2009;
Prandini et al., 2012; Connolly et al., 2013). Cadherin-9 is highly
expressed in hippocampus where it is required for formation of
dentate gyrus–CA3 synapses (Williams et al., 2011). In contrast,
cadherin-10 is highly expressed in the neocortex (Bekirov et al.,
2002; Gil et al., 2002;Wang et al., 2009), including frontal regions
relevant for ASD, but remains uncharacterized at the cellular
level.
Classical cadherins are single-pass transmembrane glycoproteins
with a cytoplasmic domain thatmediates downstream signaling and
a large extracellular domain that engages in homophilic and hetero-
philic adhesion. The classical cadherin family includes type I cad-
herins, exemplified by N-cadherin and E-cadherin, and type II
cadherins, including cadherin-6, -8, -9, and -10. Type I cadherins
have a broad tissue distribution, whereas type II cadherins are
restricted to specific brain regions or circuits (Suzuki et al., 1997).
Research to date has focused on type I cadherins. Recent studies
have identified diverse functions for type II cadherins in cerebel-
lar, retinal, and hippocampal circuits (Williams et al., 2011; Duan
et al., 2014; Kuwako et al., 2014), but very little is yet known about
the function(s) of type II cadherins in cerebral cortex.
Here, we show that cadherin-10 is important for maintaining
the balance between excitatory and inhibitory synapse function
in cortical neurons. Using immunogold-electron microscopy
(EM) and super-resolution microscopy, we demonstrate that
cadherin-10 is distributed at both excitatory and inhibitory syn-
apses as nanoscale puncta, the number and position of which
correlate with PSD size. Reducing levels of cadherin-10 exerts
complementary effects on excitatory and inhibitory synapse size
and function, leading to reduced excitation and increased inhibi-
tion. Cadherin-10mediates these effects via participation in com-
plexes with PSD-95 and gephyrin. Together, our data suggest a
new mechanism whereby a protein encoded by a common risk
locus for ASD maintains appropriate E/I ratio by reciprocal ac-
tions on excitatory and inhibitory synapses.
Materials andMethods
Antibodies. The following antibodies were purchased: mouse anti-
PSD-95 monoclonal (RRID:AB_2292909; Neuromab), mouse anti-GFP
monoclonal (RRID:AB_1587098; Millipore), chicken anti-GFP poly-
clonal (RRID:AB_300798; Abcam), mouse anti-myc monoclonal (Uni-
versity of Iowa Hybridoma Bank and RRID:AB_627266; Santa Cruz
Biotechnology), rabbit anti-cadherin-10 polyclonal (T2, to the C ter-
minus, RRID:AB_2275951; Santa Cruz Biotechnology), mouse anti-
turboGFP (RRID:AB_2622256; Origene), rabbit anti-2 GABAAR
(RRID:AB_2108839; Synaptic Systems), mouse anti-gephyrin (RRID:
AB_887716 for immunocytochemistry, RRID:AB_887719 for Western
blot; Synaptic Systems), anti-synaptophysin antibody (RRID:AB_477523;
Sigma-Aldrich), rabbit anti-GluA1 (RRID:AB_1977216; Millipore),
mouse anti-3-GABAAR (RRID:AB_2109585; Neuromab), mouse anti-
NL2 (RRID:AB_993011; Synaptic Systems), mouse anti-NL1 (RRID:
AB_2235964; Neuromab), mouse anti-Caspr2 (RRID:AB_2245198;
Neuromab), anti-N-cadherin (RRID:AB_398236; BDBiosciences). Goat
anti-mouse IgG, anti-rabbit IgG, or anti-chicken IgG antibodies conju-
gated with Alexa Fluor 488 (RRID:AB_143165, RRID:AB_143160, and
RRID:AB_142924) or Alexa Fluor 568 (RRID:AB_144696 and RRID:
AB_141416; Invitrogen) were used as secondary antibodies in immuno-
staining experiments. Horseradish peroxidase-conjugated anti-mouse
IgG (RRID:AB_228307) and anti-rabbit IgG (RRID:AB_228341) anti-
bodies (Thermo Fisher Scientific) were used as secondary antibodies in
Western blotting experiments.
Plasmids. Myc-tagged cadherin-10 and small hairpin RNA (shRNA)
constructs against cadherin-10 were purchased from Origene (RRID:
SCR_008985). The shRNA targeted nucleotides 384–413 of the cadherin-10
open reading frame (NCBI Reference Sequence: NM_009865.2). The shRNA
was expressed under the U6 promoter in pGFP-V-RS (Origene; RRID:
SCR_008985). A turbo-GFP gene under a CMV promoter was expressed
from the same plasmid to enable identification of transfected cells. The con-
trol is a scrambled target sequence, purchased from Origene. The RNAi-
resistantmyc-cadherin-10 construct was produced using theQuick Change
mutagenesis protocol.
Cortical slice preparation and imaging.Male Sprague Dawley rats were
deeply anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and int-
racardially perfusedwith 4%paraformaldehyde (PFA) in phosphate buf-
fer (PB; 0.1 M, pH 6.8) for light microscopy or a mixture of 2% PFA and
2% glutaraldehyde in PB for EM. Brains were then removed and post-
fixed for 2 h in the same fixative. Brains were cut at 40 and 100 m on a
vibratome. Forty-micrometer free-floating sections were incubated in
10% normal donkey serum and then in primary antibody, followed by
donkey IgG conjugated to DyLight 488 and DyLight 549. Slices were
imaged using a Leica SP2 microscope, and 36 single-plane high-resolution
fields (20 20m) from three rats were analyzed using Velocity software.
EM and analysis. One hundred-micrometer sections were pretreated
in 0.1% calcium chloride in 0.1 M sodium acetate, rinsed, and cryopro-
tected in a graded series to 30% glycerol in 0.1 M sodium acetate. Sections
were quick-frozen inmethanol chilledwith dry ice. Freeze substitution in
4% uranyl acetate in methanol was performed in a Leica Electron Mi-
croscopy Automatic Freeze Substitution System; after rinsing in metha-
nol, sections were infiltrated with Lowicryl HM-20, mounted between
sheets of ACLAR supported by pieces of glass slice, and polymerized with
ultraviolet light.
Sections were glued to plastic blocks, cut at70–90 nmwith an ultra-
microtome and collected on nickel grids. Grids were pretreated 15min at
60°C in 0.01 M citrate buffer, pH6, rinsed in water, blocked in 1% BSA in
Tris-buffered saline with 0.005% Tergitol NP-10, and incubated over-
night at 21–24°Cwith the primary antibodies. Grids were rinsed, blocked
in 1% normal goat serum, and incubated in secondary antibodies for 2 h
(for single labeling: goat antibody to rabbit IgG F(ab)2 conjugated to 10
nmgold particles; for double labeling: goat antibody to rabbit IgG F(ab)2
conjugated to 20 nm gold particles and goat antibody to mouse IgG
F(ab)2 conjugated to 10 nm gold particles; Ted Pella). Grids were then
rinsed and counterstained with 1% uranyl acetate, followed by Sato’s
lead. Electron microscopy was performed with a Philips Tecnai electron
microscope at 80 kV with a magnification at 10,000–40,000; images
were acquired with a Gatan 12-bit 1,024 1,024 CCD camera. Random
grid squares were chosen, and image acquisition was done with the ob-
server blind to the study. Synapses were analyzed if they were asymmetric
and had well defined membranes, postsynaptic densities, and presynap-
tic terminals with synaptic vesicles. Positions of gold particles were mea-
sured using ImageJ (National Institutes of Health; RRID:SCR_003070);
data were analyzed using Kaleidograph software.
Neuronal cell culture and transfection. Dissociated cultures of primary
cortical neurons were prepared fromE18 SpragueDawley rat embryos of
either sex, as previously described (Smith et al., 2014). Briefly, brains
were dissected in ice-coldHBSS, and cortical tissue was isolated, digested
with papain [Sigma; diluted in Neurobasal with EDTA (0.5 mM) and
DNaseI (2 units/ml), activated with L-cysteine (1 mM) at 37°C], and
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mechanically dissociated in neuronal feeding medium [Neurobasal plus
B27 supplement (Invitrogen) plus 0.5 mM glutamine plus penicillin/
streptomycin].Neuronswere plated on coverslips previously coatedwith
poly-D-lysine (0.2 mg/ml; Sigma), at 300,000 cells per coverslip in neu-
ronal feeding medium. One hour after seeding, medium was replaced.
Neuronal cultures were maintained at 37°C in 5% CO2. Neuronal feed-
ing medium was supplemented with 200 M D,L-amino-phospho-
novalerate (Ascent Scientific) beginning on DIV 4. For transfection,
plasmids (1–10 g total DNA) and Lipofectamine 2000 (Invitrogen)
were diluted in DMEM plus HEPES (10 mM), mixed thoroughly to-
gether, and incubated for 20–30 min at 37°C before adding to cultured
neurons. After transfection, antibiotic containing feeding medium con-
taining half-conditioned and half-fresh medium was added to the cul-
tures, and the constructs were expressed for 3 d or as indicated.
HEK293 cell transfection. HEK293 cells were maintained in DMEM
(Invitrogen), supplemented with 10% heat-inactivated fetal bovine se-
rum and penicillin–streptomycin, and transfected by Lipofectamine
2000 as described above. Plasmids were expressed for 48 h and harvested
in pull-down buffer [50 mM Tris, pH 7.5, 1% Triton X-100, 150 mM
NaCl, with protease inhibitor cocktail (Roche)] for SDS-PAGE and
Western blotting.
Immunocytochemistry. Neurons were fixed for 10 min in 4% formal-
dehyde/4% sucrose in PBS and then at 4°C in methanol prechilled to
20°C for 10 min. Fixed neurons were permeabilized and blocked si-
multaneously in PBS containing 2%normal goat serum and 0.2%Triton
X-100 for 1 h at room temperature. Primary antibodies were added in
PBS containing 2% normal goat serum overnight at 4°C, followed by
three 10min washes in PBS. Secondary antibodies were incubated for 1 h
at room temperature, also in 2% normal goat serum in PBS. Three addi-
tional washes (15 min each) were performed before coverslips were
mounted using ProLong antifade reagent (Invitrogen).
Confocal microscopy. Confocal images of immunostained neurons
were obtained with a Ziess LSM5 Pascal confocal microscope. Images
were taken using the 63 oil-immersion objective (NA 1.4) collecting a
z-series of 5–10 images, averaged two times, and taken at 0.37 m inter-
vals with 1024  1024 pixel resolution. Detector gain and offset were
adjusted in the channel of cell fill (GFP) to include all spines and to
enhance edge detection.
Dendritic spine quantification.Two-dimensional, background-subtracted
maximumprojection reconstructions of images for dendritic spinemor-
phometric analysis (area, length, and width) and quantification of spine
linear density (number of spines/10 m dendritic length) were per-
formed using MetaMorph software (Molecular Devices) as described
previously (Smith et al., 2014). Briefly, a threshold was applied to the
maximumprojection images to include all detectable spines, and regions
along dendrites containing dendritic spines were manually traced to en-
close spines but not the dendritic shaft or other structures. Dendritic
spine “objects,” restricted to objectswith areas0.1m2,were automat-
ically detected byMetaMorph, and the area, maximum length, and head
width of each spine were measured. Two dendritic branches (100m)
of each neuron were analyzed. Only spines on secondary and tertiary
apical dendrites were measured to reduce variability. Cultures that were
directly compared were stained simultaneously and imaged with the
same acquisition parameters. For each condition, 3–10 neurons each
from three to five separate experiments were used. Experiments were
performed blind to conditions and on sister cultures.
Confocal image analysis. Colocalization of synaptic proteins (PSD-95
and gephyrin) with cadherin-10 was quantified using MetaMorph.
Background-subtracted images were thresholded, regions along den-
drites were outlined, and total immunofluorescence intensity for each
cluster was measured automatically. To determine the degree of colocal-
ization between two channels, each channel was thresholded to select
distinct puncta as described above. A 100 m dendritic region was se-
lected, and puncta counts were made; puncta smaller than 0.065 m2
were excluded from analysis. Regions representing the measured puncta
in one channel were generated using MetaMorph and overlaid onto the
other channel. Puncta were counted as colocalized (positive) if the aver-
age intensity within the overlaid region exceeded threshold. Thresholds
were set individually for each antibody and held constant across all
images.
Structured illuminationmicroscopy.Multichannel structured illumina-
tionmicroscopy (SIM) images were acquired as described by Smith et al.
(2014), using a Nikon Structured Illumination super-resolution micro-
scope with 100 (NA 1.4) objective. During acquisition, auto-exposure
was kept between 100 and 300 ms and laser power was adjusted to keep
Lookup tables (LUTs) within the first quarter of the scale (4000).
Z-stacks (z  0.2 m, seven to eight slices) were reconstructed using
Nikon Elements software. Three reconstruction parameters (Illumina-
tionModulation Contrast, High Resolution Noise Suppression, and Out
of Focus Blur Suppression) were extensively tested to generate consistent
images across experiments without abnormal features or artifacts and
producing the best Fourier transforms. Reconstruction parameters (0.96,
1.19, and 0.17) were kept consistent across experiments and imaging
sessions. Resolution of images was confirmed with full-width half-
maximum (FWHM) measurements of a small structure within the
image.
SIM analysis. Imageswere processed and analyzedusingNikonElements
software (RRID:SCR_014329),MetaMorph (RRID:SCR_002368), and Im-
ageJ and displayed asmaximumprojections. Single PSD-95 and gephyrin
analyses were performed on180 PSDs across four to five neurons per
condition using Nikon Elements or ImageJ software. PSD-95, gephyrin,
and cadherin-10 diameters were assessed as the FWHMandmeasured in
ImageJ with a line scan across the maximumwidth of the cluster. Gauss-
ian fits of these intensity profiles were performed in GraphPad Prism,
and the FWHMwas calculated. Visual assessment of fluorescence inten-
sity was used to delineate separate or connected puncta. We only took
into account the position of cadherin-10 puncta that touched or over-
lapped with synaptic staining (i.e., both perisynaptic and central that
touched the synaptic cluster). A cadherin-10 punctum that was touching
or overlapping with a gephyrin or PSD-95 puncta was included in the
analyses. This was achieved by visual assessment of fluorescence intensity
between the cadherin-10 punctum and the PSD. Puncta were considered
separate if a region of decreased intensity was readily visible between the
puncta and the PSD. This approach was then confirmed with the Nikon
Elements automated detection software and kept consistent throughout
all analyses. The number of cadherin-10 puncta associated with the PSD
was quantified manually and recorded. Based on the localization of
cadherin-10 with respect to the PSD, synapses were classified into one of
three groups. The central group included synapses with cadherin-10
puncta entirely enveloped by the PSD and not touching the edge of the
PSD. The perisynaptic group contained synapses that harbored cadherin-10
puncta that were confined to and touching the edge of the PSD. The
central/perisynaptic group contained synapses that had at least one
cadherin-10 punctum that was perisynaptic, and one cadherin-10 punc-
tum that was central.
Electrophysiology. Cultured cortical neurons were recorded in whole-
cell configuration 3 d after transfection (DIV 24) as described previously
(Smith et al., 2014). The extracellular solution contained 140 mM NaCl,
10mM glucose, 10mMHEPES, 3mMKCl, 2 mMCaCl2, and 1mMMgCl2,
pH 7.3. Patch pipettes were pulled from borosilicate glass and fire-
polished to a resistance of 3–5M. The intracellular patch-pipette solu-
tion contained 95 mM CsF, 25 mM CsCl, 10 mM HEPES, 10 mM EGTA,
2 mMNaCl, 2 mMMg-ATP, 10 mMQX-314, 5 mM tetraethylammonium
chloride, and 5 mM 4-amino- pyridine, pH 7.2. Neurons were voltage
clamped at 70 mV, and currents were recorded using pClamp9 soft-
ware with an Axopatch 200B amplifier (Molecular Devices). Miniature
EPSCs (mEPSCs) were isolated by bath application of 10M bicuculline,
50M picrotoxin, 50M D,L-aminophos-phonovalerate, and 1M tetro-
dotoxin. Verification that mEPSCs were mediated by AMPA receptors
was achieved by adding 50MCNQX at the end of recordings.Miniature
IPSCs (mIPSCs) were isolated by the addition of APV (50 M) and
CNQX (20 M). Recordings were filtered at 5 kHz and digitized at 20
kHz. The data were low-pass filtered using a 1 kHz cutoff and analyzed
blind to condition with Mini-Analysis software (Synaptosoft).
Coimmunoprecipitation assays. DIV 20–22 cortical neurons or ho-
mogenized rat cortexwere solubilized for 1 h in pull-down buffer [50mM
Tris, pH 7.5, 1% Triton X-100, 150 mM NaCl, with protease inhibitor
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cocktail (Roche)]. Solubilized material was centrifuged at 16,000 g for
10 min at 4°C, and the supernatant was precleared with protein G beads
for 1 h. Proteins were immunoprecipitated with 2 g of cadherin-10
antibody for 2 h, followed by a 1 h incubation with protein G beads.
Beads were then washed four times, and bound complexes were analyzed
by SDS-PAGE and Western blotting.
Membrane fractionation.Cortices from 6-week-oldmice were homog-
enized in sucrose buffer (20 mM HEPES, pH 7.4, 320 mM sucrose, and 5
mM EDTA) supplemented with protease inhibitor cocktail (Roche). Ho-
mogenates were centrifuged at low speed to pellet nuclei and cell debris
(3000 g for 20 min at 4°C), and the supernatant (S1) was then centri-
fuged at high speed (38,000 g for 30min at 4°C) to obtain amembrane
pellet (P2). P2 was resuspended in potassium iodide buffer (20 mM
HEPES, pH 7.4, 1 M KI, and 5 mM EDTA) to remove membrane-
associated proteins (S3), andmembranes were again collected by centrif-
ugation (38,000 g for 20min at 4°C).Membranes were washed (20mM
HEPES, pH 7.4, and 5 mM EDTA) and pelleted once more (S4) before
solubilizing in CHAPS buffer supplemented with protease inhibitors
(20mMHEPES, pH 7.4, 100mMNaCl, 5mM EDTA, and 1%CHAPS) for
2 h at 4°C. Solubilizedmembranes were clarified by centrifugation for 30
min at 100,000  g at 4°C (S5). The final CHAPS-insoluble pellet was
resuspended in SDS buffer (50 mM Tris, pH 7.4, 150 mM NaCl, and 1%
SDS) supplemented with protease inhibitors, solubilized at 37°C for 20
min, and clarified by centrifugation (S6).
Experimental design and statistical analysis. N numbers refer to the
number of cells per condition unless otherwise stated. All experiments
were performed at least three times from three separate neuron cultures.
All statistical tests were performed with GraphPad Prism. Data were
tested for normality with D’Agostino and Pearson’s tests to determine
use of nonparametric (Mann–Whitney test, Kruskal–Wallis test, Spear-
man’s correlation) or parametric (t test, ANOVA, Pearson’s correlation)
tests, as described in the text. Comparisons between two sets of data were
performed with an unpaired t test. Data with three or more groups were
analyzed by one-way ANOVA, followed by Bonferroni’s post hoc com-
parison. Spearman’s or Pearson’s correlation was used to evaluate corre-
lations between numbers of cadherin-10 puncta and PSD-95 or gephyrin
cluster diameters. Two-way ANOVA was used to analyze differences in
the distribution of cadherin-10 puncta relative to gephyrin and PSD-95
clusters, followed by a Bonferroni’s post hoc comparison. P values were
considered significant if less than 0.05. Bar graphs are displayed as
mean	 SEM, unless otherwise noted.
Results
Expression and distribution of cadherin-10 in cortex
Cadherin-10 is reported to be enriched in frontal cortex and the
CA1 region of the hippocampus (Bekirov et al., 2002; Gil et al.,
2002; Wang et al., 2009; Fig. 1A), although its precise cellular
localization and function in these regions remains unknown. To
study its expression, we used a cadherin-10 antibody, which iden-
tifies a single band at the correct molecular weight by Western
blotting of rat brain lysate and recognizes exogenously expressed
Figure 1. Expression and distribution of cadherin-10 in cortex. A, In situ hybridization of cadherin-10, reproduced from the Allen Brain Atlas database showing high expression of cadherin-10 in
cerebral cortex and CA1 region of hippocampus. Scale bars, 1mm.B, RepresentativeWestern blot (WB) of whole brain lysate, probedwith cadherin-10 antibody (n 4 independent experiments).
C, Representative WB of lysates from HEK293 cells expressing myccadherin-10, GFPN-cadherin, or untransfected control (UT). Blots are probed with antibodies to cadherin-10 or GFP (n 3
independent experiments).D, Lightmicroscopy image of layer 2/3 of cerebral cortex immunostained for cadherin-10. Scale bar, 10m. E, Enlargement of the boxed region inD, immunostained for
cadherin-10 (green) and synaptophysin (red); closely apposed puncta are marked with solid white circles and overlapping puncta with dotted circles. Scale bar, 2m. F, Quantification of cad-
herin-10 and synaptophysin (Syn.) colocalization showing 37 	 5% of cadherin-10 clusters were positive (pos.) for synaptophysin and 40 	 2% synaptophysin clusters were positive for
cadherin-10.
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cadherin-10 but does not recognize exogenously expressed
N-cadherin (Fig. 1B,C). We labeled histological sections from
adult rat forebrain with antibodies to cadherin-10 and the pre-
synaptic marker synaptophysin, focusing our attention on layer
2/3. Cadherin-10 was organized into numerous puncta through-
out the neuropil (Fig. 1D): 40% were colocalized with synap-
tophysin clusters (Fig. 1E), suggesting association of cadherin-10
with synaptic sites.
Figure 2. Cadherin-10 is localized to excitatory and inhibitory presynaptic and postsynaptic sites. A, Immunogold-EM micrographs of excitatory and inhibitory synapses from layer 2/3 of
neocortex. A glutamatergic terminal is colorized in pink, a postsynaptic spine in green, a GABAergic terminal in blue, and opposing postsynaptic dendrites in yellow. Large dots are gold particles
coding for cadherin-10, and small dots code forGABA.Arrowheadspoint to cadherin-10 immunoreactivity. Scalebars, 200nm.B,C, Quantitative analysis of cadherin-10goldparticle position relative
to the postsynaptic plasma membrane in the perpendicular axis (B) and lateral position tangentially along the plasma membrane (C; position 0, central; position 1, perisynaptic; position 2,
extrasynaptic; 100 synapses from 4 rats). D, Confocal image of DIV 21 cortical dendrite expressing GFP and immunostained with antibodies to cadherin-10. Scale bar, 5m. Arrowheads point to
cadherin-10 in spines, and open arrowheads point to cadherin-10 in the dendritic shaft. E, Confocal images of DIV 21 cortical dendrites immunostainedwith antibodies to cadherin-10 PSD-95 (left)
and gephyrin (right); bar graphs quantify the percentage of cadherin-10 (Cad-10) clusters that colocalize with synaptic marker clusters. Scale bars, 5 m. F, Confocal image of cortical neuron
expressing myccadherin-10 and GFP. Filled arrowheads point to cadherin-10 puncta in spines, and open arrowheads point to cadherin-10 in the dendritic shaft. Scale bar, 5m. G, Confocal image
of cortical neuron expressing myccadherin-10 and immunostained with antibodies to vesicular GABA transporter to identify GABAergic terminals.
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Figure3. Cadherin-10 formsnanoscale puncta at cortical synapsesA, SIM imagesof cortical dendrites immunostained for cadherin-10andPSD-95or gephyrin (maximumprojections of z-stacks).
Filled arrowheads point to cadherin-10-positive clusters, and open arrowheads point to cadherin-10-negative clusters. Scale bar, 2 m. B, High-magnification views of cadherin-10 puncta at
PSD-95 and gephyrin clusters. White lines show the path of line scans represented in the graphs below the images. C,D, Confocal image of a DIV 24 cortical neuron immunostained for cadherin-10
and PSD-95 (scale bar, 5m; maximum projection of z-stack). The boxed region is shown at higher magnification below. White lines (a
 and b
) produced line scans in D showing similar cluster
diameter for cadherin-10 and PSD-95 when imaged by confocal microscopy. E, Top, High-magnification SIM image showing the small cadherin-10 cluster lies (Figure legend continues.)
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Cadherin-10 is localized to excitatory and inhibitory
presynaptic and postsynaptic sites
Cadherin-10 displays homophilic adhesion (Shimoyama et al.,
2000), suggesting that postsynaptic cadherin-10 might interact
with a presynaptic pool of cadherin-10 to mediate adhesion at
synapses. To assess presynaptic versus postsynaptic location of
cadherin-10, we performed immunogold-EM, which showed
cadherin-10 labeling was both at the presynaptic active zone and
the PSD of excitatory synapses (Fig. 2A). Double labeling for the
inhibitory neurotransmitter GABA revealed that cadherin-10
gold particles were also present presynaptically and postsynapti-
cally at inhibitory synapses. Quantitative analysis of gold-particle-
labeled cadherin-10 in cortex (from four rats, 25 synapses per rat)
showed that48% of gold particles lay within 20 nm of the mem-
brane (Fig. 2B). Further analysis of the lateral position of gold
particles along the plasma membrane showed that membrane-
associated cadherin-10 was strongly associated with the synaptic
specialization, both at the presynaptic and postsynaptic sites (Fig.
2C). Indeed, the presence of cadherin-10-labeled gold particles
was12-fold higher within the synapse (central and perisynaptic
positions 0 and 1) comparedwith extrasynaptic regions (position
2). Together, these data support both presynaptic and postsyn-
aptic localization for cadherin-10 at both excitatory and inhibi-
tory synapses in layer 2/3 cortex.
We then wanted an in vitro system to facilitate experimental
manipulation, but first we verified that cadherin-10 displayed the
same pattern of synaptic localization as shown in the intact brain.
Using confocal microscopy, to allow good spatial separation of
synapses, we characterized the localization of cadherin-10 in a
mature low-density cortical culture system. Cadherin-10 ap-
peared as discrete puncta throughout the dendritic tree, distrib-
uted both along the dendritic shaft and in dendritic spines, as
demonstrated by labeling of GFP-filled neurons (Fig. 2D).
Cadherin-10 was present at both PSD-95 and gephyrin-positive
clusters, confirming localization at excitatory and inhibitory syn-
apses (Fig. 2E). Furthermore, exogenous myc-tagged cadherin-10
was expressed in dendritic spines (the main locus of excitatory
synapses) and colocalized with the inhibitory synaptic marker
vesicular GABA transporter (Fig. 2F,G), confirming that post-
synaptic cadherin-10 is localized at both types of synapses. To-
gether, these data place cadherin-10 in an ideal position to
modulate both excitatory and inhibitory synaptic adhesion and,
hence, excitatory and inhibitory synapse function.
Super-resolution imaging of cadherin-10 at synapses
Super-resolutionmicroscopy offers a newwindow into the nano-
scale organization of synaptic proteins (Frost et al., 2010;MacGil-
lavry et al., 2013; Nair et al., 2013; Lu et al., 2014; Smith et al.,
2014). SIM (Gustafsson, 2005; Smith et al., 2014) enabled us to
determine the subsynaptic distribution of cadherin-10 at excit-
atory and inhibitory synapses over a broader field of view and
with higher immunocytochemical sensitivity than offered by
postembedding immuno-EM. We imaged cortical neurons im-
munolabeled with antibodies to cadherin-10 and either PSD-95
or gephyrin to label excitatory and inhibitory PSDs, respectively
(Fig. 3A). SIM imaging revealed that cadherin-10 is organized
into nanoscale subsynaptic puncta (Fig. 3A,B), rather than a sin-
gle homogenous complex like PSD-95 or gephyrin. Additionally,
cadherin-10 clusters were frequently distributed around the pe-
rimeter of the PSD-95 or gephyrin cluster, as demonstrated by
line scans across the clusters (Fig. 3B). These features of cadherin-10
puncta contrast strikingly with line scans from lower-resolution
conventional confocal images, which show cadherin-10 puncta to
have similar sizes as PSD-95 clusters (Fig. 3C,D). In comparison,
our SIM images show that cadherin-10 puncta have a mean di-
ameter of 0.196	 0.003 m (Fig. 3E), significantly smaller than
either PSD-95 (0.409 	 0.009 m) or gephyrin (0.335 	 0.008
m; p  0.0001, Kruskal–Wallis test; Fig. 3F–I) clusters. Al-
though associated with both PSD-95 and gephyrin, cadherin-10
puncta displayed a preference for PSD-95-positive synapses;
80% of PSD-95 clusters harbored cadherin-10 puncta com-
pared with only 51% of gephyrin clusters (*p  0.012, t test;
Fig. 3J). SIM, therefore, places cadherin-10 in synaptic nanoclus-
ters that are associated with both excitatory and inhibitory PSDs.
Cadherin-10 is required for maintaining appropriate E/I
synapse ratio in cortical neurons
The presence of cadherin-10 puncta at both excitatory and inhib-
itory synapses suggests that they may play a role in maintaining
synaptic structure at these sites. To test this hypothesis, we used
RNAi to knock down cadherin-10. We tested four RNAi con-
structs in cadherin-10-expressing HEK293 cells (Fig. 4A,B), us-
ing the most effective (RNAi 2) in our experiments with cultured
cortical neurons. This RNAi had no effect on N-cadherin expres-
sion levels (Fig. 4B) but effectively knocked down cadherin-10 in
cortical neurons (Fig. 4C). DIV 21 cortical neurons were trans-
fected with control and cadherin-10 constructs and fixed for sub-
sequent analysis at DIV 24. Confocal imaging of control and
cadherin-10 knock-down neurons and analysis of spine dimen-
sions and density revealed a 20% decrease in spine area (p 
0.0043, one-way ANOVA; Fig. 4D,E), reflecting a reduction in
both spine width and length (Fig. 4E), and could be rescued by
coexpression with RNAi-resistant cadherin-10 (Fig. 4E). There
was a slight reduction in spine density with cadherin-10 RNAi
that did not reach significance (Fig. 4D,E). Therefore, we con-
clude that cadherin-10 plays an important role in maintaining
existing excitatory synapse structure.
We then analyzed inhibitory GABAA receptor (GABAAR)
clusters in control and knock-down neurons. Unexpectedly, we
found that cadherin-10 knockdown caused a 22% increase in the
GABAAR cluster area (p 0.0258, one-way ANOVA; Fig. 4F,G),
which could be rescued by coexpression with RNAi-resistant
cadherin-10, accompanied by a slight increase in cluster density
that did not reach significance (p 0.05, one-way ANOVA; Fig.
4F,G). As the areas of dendritic spines and synaptic GABAAR
clusters provide readouts of excitatory and inhibitory synaptic
strength, respectively (Nusser et al., 1997; Sala and Segal, 2014),
we calculated the ratio between spine and GABAAR cluster areas
in the same dendritic segment to compute an estimate of excit-
atory/inhibitory ratio per dendrite. This revealed that the ratio
between excitatory and inhibitory synapse size was significantly
reduced by 40% in cadherin-10 knock-down neurons com-
pared with controls (p 0.010, t test; Fig. 4H).
4
(Figure legend continued.) adjacent to the large gephyrin cluster. To analyze the cadherin-10
puncta diameter, we generated a line scan (right, red line). Bottom, Gaussian fit of pixel-
intensity profile across the cadherin-10 cluster. FWHM of profile was used to determine cluster
diameter. F,H, Frequency distributions of PSD-95 (F), gephyrin (G), and cadherin-10 (H) cluster
diameter. I, Mean diameter of PSD-95, gephyrin, and cadherin-10 clusters; PSD-95, 0.409	
0.009m; gephyrin, 0.335	 0.008m; cadherin-10, 0.196	 0.003m; ****p 0.0001,
Kruskal–Wallis test; n 132–195 PSDs. J, Percentages of cadherin-10-positive PSD-95 and
gephyrin clusters (PSD-95, 80.6	 5.4%; gephyrin, 49.4	 6.7%; *p 0.012, t test; n 4–5
neurons).
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Cadherin-10 is required for maintaining correct excitatory
and inhibitory synaptic strength in cortical neurons
To determine whether these structural alterations were reflected
by changes in synapse function, we then performed whole-cell
electrophysiological recordings of mEPSCs and mIPSCs from
control and cadherin-10 knock-down neurons (DIV 21 transfec-
tion, DIV 24 analysis; Fig. 5A). Consistent with our immunoflu-
orescence data, cadherin-10 knockdown caused a reduction in
mEPSC amplitude but an increase in mIPSC amplitude (mEP-
SCs, p  0.040; mIPSCs, p  0.034; t test; Fig. 5B,C). Impor-
tantly, neither mEPSC nor mIPSC frequency was significantly
altered (Fig. 5D). Together with our imaging results (Fig. 4),
these data indicate that cadherin-10 is required to maintain
the proper ratio between the strength of excitatory and inhib-
itory synapses in dendrites of cortical neurons, without affect-
ing their numbers.
Association of cadherin-10 with excitatory and inhibitory
synaptic proteins
To elucidate mechanisms underlying the regulation of excitatory
and inhibitory synapses by cadherin-10, we examined its
interactions with major synapse type-specific molecules. Coim-
munoprecipitations (coIPs) of cadherin-10 from cultured corti-
cal lysates, followed by probing for interactions of synaptic
proteins, revealed that cadherin-10 robustly participates in a
complex with PSD-95 (Fig. 6A). We also observed a weak inter-
action between cadherin-10 andN-cadherin, suggesting that they
may participate together in complexes at some synapses. How-
ever, we found no evidence of an association of cadherin-10 with
multiple other adhesionmolecules andneurotransmitter receptors.
Cadherin-10 coIPs performed with rat cortical lysate demon-
strated that cadherin-10 also associates with PSD-95 in vivo, sug-
gesting this complex might be important for cadherin-10
function in the intact brain (Fig. 6B). Surprisingly, we did not
detect coIP of the inhibitory scaffold gephyrin with cadherin-10
(Fig. 6A). However, the reverse coIP with gephyrin antibodies
readily precipitated cadherin-10 (Fig. 6C), supporting the pres-
ence of cadherin-10 at inhibitory synapses in cortex. This result
could be explained by the relative distributions of these proteins,
assuming that a large proportion of gephyrin participates in com-
plexes with cadherin-10 but a smaller fraction of cadherin-10
participates in complexes with gephyrin. To compare the relative
synaptic distribution of N-cadherin and cadherin-10, we per-
formed membrane fractionation experiments from mouse cor-
tex, finding that N-cadherin is mainly associated with the
membrane and PSD fractions (Fig. 6D), consistent with previous
evidence that this type I cadherin is exclusively at excitatory PSDs
(Benson and Tanaka, 1998). In contrast, cadherin-10 was present
also in fractions containing membrane-associated proteins (usu-
ally associated with inhibitory synaptic components) as well as
the PSD, supporting its presence at both synaptic sites.
Figure 4. Cadherin-10 knockdown reduces E/I synapse ratio in dendrites of cortical neurons A, Western blot (WB) analysis of lysates fromHEK293 cells expressing myccadherin-10 alone, or with
GFP-expressing control or candidate RNAi constructs. The red box highlights effects of RNAi 2.B, Quantification of cadherin-10 RNAi knockdown in HEK293 cells. RNAi construct 2, which proved very
effective, had no effect on N-cadherin expression andwas used for all experiments (****p 0.0001, 1-way ANOVA; n 3 independent experiments). C, Maximumprojections of confocal z-stacks
showing cortical neurons expressing control or cadherin-10 RNAi and immunostained with antibodies to cadherin-10. Scale bar, 20m. Arrowheads point to cadherin-10 expression in soma and
dendrites of neurons. Bar graphs show quantification of cadherin-10 in the soma and dendrites of control and knock-down neurons (**p 0.0019; ***p 0.0009; n 6 –9 neurons).
D, Maximum projections of confocal z-stacks showing control, cadherin-10 knockdown, or knockdown and rescue expressing DIV 24 cortical neurons; neurons also express GFP to outline
the dendrite. Scale bar, 5m. E, Quantification of spine area, width, length, and density (area, **p 0.0043; width,**p 0.0037; length,*p 0.0424; density, p 0.05; n 19 –20
neurons). F, Maximumprojections of confocal z-stacks showing control, cadherin-10 knockdown, or knockdown and rescue of GFP-expressing DIV 24 cortical neurons (green) labeledwith
antibodies to 2-GABAAR clusters (red). Scale bar, 5 m. G. Quantification of 2-GABAAR cluster area and density (area, *p 0.0258; density, p 0.05; n 17–23 neurons). H,
Quantification of ratio of spine area to GABAAR cluster area in the same dendrite. The bar graph shows the E/I ratio is reduced from 4.9	 0.5 to 3.0	 1.3 in cadherin-10 knock-down
neurons (E/I: *p 0.010, n 10 –12 neurons).
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Nanoscale distribution of cadherin-10 puncta impacts
synaptic scaffold dimensions
Analysis of SIM images of cadherin-10 and either PSD-95- or
gephyrin-labeled neurons revealed that PSD-95 clusters har-
bored significantly larger numbers of cadherin-10 puncta com-
pared with gephyrin clusters (p  0.0001, Mann–Whitney test;
Fig. 7A), even when normalized to the PSD cluster diameter (p
0.0001, Mann–Whitney test; Fig. 7A), indicating that the larger
number of cadherin-10 puncta at PSD-95-positive clusters is not
only attributable to their larger size. We found that cadherin-10
puncta could be central (overlapping completely with the PSD),
perisynaptic (contacting the edge of the PSD), or both central and
perisynaptic (Fig. 7B). We categorized each PSD according to
these three groups. The distribution patterns of cadherin-10
puncta were similar at PSD-95 and gephyrin PSDs (p  0.05,
two-way ANOVA; Fig. 7C). The majority of cadherin-10 puncta
at both excitatory and inhibitory synapseswere perisynaptic: only
10–20% of PSDs had either central puncta or a combination of
central and perisynaptically positioned puncta. A significantly
higher percentage of gephyrin clusters completely lacked cadherin-10
comparedwithPSD-95clusters (p0.001, two-wayANOVA,Bon-
ferroni’s post hoc test; Fig. 7C). Comparing the diameters of PSDs
with different cadherin-10 localization patterns revealed that
PSD-95 and gephyrin clusters with both perisynaptic and cen-
trally distributed cadherin-10 puncta were significantly larger
than PSDs with no cadherin-10 or other distributions (p 
0.0005, p 0.0132, one-way ANOVA; Fig. 7D). Thus, the nano-
scale position of cadherin-10 puncta may be related to the size of
the PSD at both excitatory and inhibitory synapses.
Our data show that cadherin-10 associates more robustly and
displays more extensive colocalization with PSD-95 than gephy-
rin. We then asked whether cadherin-10 abundance was differ-
entially related to the size of excitatory versus inhibitory synapses.
We found a strong positive correlation between the number of
cadherin-10 puncta and the diameter of the associated PSD-95
cluster (p  0.0001, Spearman’s correlation; Fig. 7E,F) but a
weaker correlation that did not reach significance between the
number of cadherin-10 puncta and the size of gephyrin synapses
(p  0.056, Spearman’s correlation; Fig. 7E,F). Likewise, the
presence of cadherin-10 correlated with significantly larger
PSD-95 clusters, but not with larger gephyrin clusters (PSD-95:
p  0.015, Mann–Whitney test; Fig. 7G), thereby reflecting po-
tential differences in the association of cadherin-10 with PSD-95
compared with gephyrin. As cadherin-10 robustly interacts with
PSD-95, and PSD-95 is essential for controlling the balance be-
tween excitatory and inhibitory synapses in dendrites (Levinson
et al., 2010), we asked whether cadherin-10 knockdown altered
the levels of PSD-95 in the neuron. Analysis of PSD-95 clusters in
control and cadherin-10 knock-down neurons showed that both
cluster density and total dendritic levels of PSD-95 were signifi-
cantly reduced in cadherin-10 knock-down neurons (p 0.004,
t test; p 0.0354,Mann–Whitney test; Fig. 7H, I), indicating that
cadherin-10 may be required for maintaining the correct distri-
bution and expression levels of PSD-95 in cortical dendrites.
Discussion
Type I classical cadherins are strongly implicated inmany aspects
of synaptic function (Hirano and Takeichi, 2012), but little is yet
known about the differentially expressed type II cadherins and
their functions in the brain. We find that the type II cadherin-10
is expressed at both excitatory and inhibitory synapses in cerebral
cortex, where it regulates synapse structure and function, helping
to control the balance between excitatory and inhibitory synaptic
strength in cortical dendrites.
Cadherin-10knockdown led todepressionof excitatory synapses
and concurrent enhanced strength of nearby inhibitory synapses,
suggesting that it acts to maintain excitatory synaptic efficacy
while constraining inhibitory synapse function. Interestingly, we
Figure 5. Cadherin-10 loss reciprocally modulates excitatory and inhibitory synaptic strength. A, Representative AMPA receptor-mediated mEPSC and GABAAR-mediated mIPSC traces from
control or cadherin-10 knock-down DIV 24 cortical neurons. B, Bar graphs of mEPSC and mIPSC amplitudes showing mEPSCs are reduced from 28.7	 3.8 pA to 20.3	 1.0 pA, and mIPSCs are
increased from 24.0	 1.9 pA to 29.6	 1.7 pA (mEPSCs, *p 0.040; mIPSCs, *p 0.034; t tests; n 14–15 neurons). C, Cumulative frequency graphs of mEPSC andmIPSC amplitudes. D, Bar
graphs of mEPSC and mIPSC frequencies showing no significant difference (mEPSCs, p 0.282; mIPSCs, p 0.326; t tests; n 12–13 neurons).
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Figure 6. Cadherin-10 associates with PSD-95 and gephyrin A, Representative Western blot of cadherin-10 coIP from cultured cortical neurons (DIV 22) probed with synaptic proteins. A strong
PSD-95 band and weak N-cadherin band are visible in the immunoprecipitation lane (n 4 independent experiments). B, Representative Western blot of cadherin-10 coIP from rat cortical
homogenate, showing interaction with PSD-95 but not gephyrin (n 3 independent experiments). C, Representative Western blot of gephyrin coIP from rat cortical homogenate, showing
interaction with cadherin-10 (n 3 independent experiments). D, Representative Western blot of cortical membrane fractions. S1 and S2, crude homogenate; S3, membrane-associated protein;
S5, membrane protein; S6, PSD protein. Cadherin-10 shows a strong band in the membrane-associated fraction, whereas a comparable band is barely visible for N-cadherin (n 3 independent
experiments). IP, Immunoprecipitation; MW, molecular weight.
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Figure 7. Nanoscale distribution of cadherin-10 puncta impacts synaptic scaffold dimensionsA, Mean number of cadherin-10 puncta per PSD-95- and gephyrin-positive synapse. Gephyrin PSDs
have 50.6% fewer cadherin-10puncta comparedwith PSD-95. Data are also shownas a frequency distributionhistogram (****p0.0001,n170–195PSDs). Right, cadherin-10puncta number
at PSD-95 and gephyrin PSDs, normalized to PSD diameter (****p 0.0001, n 170–195 PSDs). B, SIM images show examples of different cadherin-10 puncta distributions. Scale bar, 0.2m;
maximumprojections of z-stacks. C, Bar graphs showing percentage of PSD-95 and gephyrin synapseswith different distributions of cadherin-10 puncta; the distribution of cadherin-10 punctawas
similar at both PSDs (2-way ANOVA, p 0.05; n 4–5 neurons). Forty-nine percent of gephyrin PSDs had no cadherin-10 compared with 20% of PSD-95 PSDs (Bonferroni’s post hoc test, **p
0.001; n 4–5 neurons). D, PSD diameter correlates with subsynaptic distribution of cadherin-10 (***p 0.0005; *p 0.0132; 1-way ANOVA; n 170–195 PSDs). E. SIM images of different
numbers of cadherin-10 puncta at PSD-95- and gephyrin-positive synapses. Scale bar, 0.2m;maximum projections of z-stack. F, Correlation between PSD-95 or gephyrin diameter and number
of cadherin-10 puncta (n 170–195 PSDs, 4–5 neurons per condition).G, Presence of cadherin-10 puncta correlates significantlywith PSD-95 diameter but not gephyrin diameter (0.365	 0.01
m to 0.419 	 0.01 m; PSD-95, *p  0.015; gephyrin, p  0.197; Mann–Whitney test; n  170–195 PSDs; 4–5 neurons per condition). H, Maximum (Figure legend continues.)
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observed little effect of cadherin-10 manipulation on synapse
number, suggesting that cadherin-10 regulates existing synapses,
unlike other classical cadherins, which are thought to help con-
trol new synapse formation early in development (Brigidi and
Bamji, 2011). Indeed, cadherins are often considered dispensable
in mature neurons, where synapses are already established (Ben-
son and Huntley, 2012), but our evidence that cadherin-10 helps
to maintain the structure and strength of both excitatory and
inhibitory synapses in mature cortical culture may be relevant
also for other type II cadherins.
We show that cadherin-10 is present at presynaptic and post-
synaptic sites of glutamatergic and GABAergic synapses, both in
situ in layer 2/3 cortical neurons and in cortical culture, forming
distinct nanoscale puncta considerably smaller than PSD-95
clusters. These puncta are small enough to contribute to the or-
ganization of the nanoscale scaffolding domains recently demon-
strated by super-resolution microscopy for both excitatory and
inhibitory PSD proteins (MacGillavry et al., 2013; Nair et al.,
2013; Specht et al., 2013). We found that the size of PSD-95
clusters, but not of gephyrin clusters, strongly correlated with the
number of associated cadherin-10 puncta, pointing to the impor-
tance of cadherin-10 for excitatory PSD integritywhile suggesting
that cadherin-10 may be less critical for inhibitory PSD integrity.
We speculate that other adhesion molecules might help to main-
tain PSD structure at inhibitory synapses.
Cadherin-10 puncta occupied perisynaptic and central posi-
tions at both excitatory and inhibitory postsynaptic densities,
which may be important for the structural organization of sub-
synaptic domains of the PSD and for the maintenance of overall
stability. The position of subsynaptic cadherin-10 clusters at the
PSDmay be an important determinant of PSD size. Alternatively,
there may be a “threshold” whereby above a certain concentra-
tion (perisynaptic and central positions) cadherin-10 supports a
larger PSD. EM studies have shown that neuroligins are localized
toward the center of the PSD (Mortillo et al., 2012), whereas
N-cadherin is enriched at the outer rims of active zones and PSDs
(Uchida et al., 1996). Furthermore, STED (stimulated emission
depletion) imaging of hippocampal synapses has revealed that
SynCAM1 is localized to the postsynaptic edges of the synaptic
cleft, in contrast to EphB2, which lies further within the PSD
(Perez de Arce et al., 2015). Interestingly, we find cadherin-10 is
distributed both at the edge and in the center of the PSD. This
places cadherin-10 puncta in a position where theymay structur-
ally contribute to the PSD of synapses.
Our data support a model whereby nanoscale subsynaptic
cadherin-10 clusters regulate E/I balance by interacting with PSD
proteins at both excitatory and inhibitory synapses (Fig. 7J). Af-
ter knockdown of cadherin-10 in mature neurons, excitatory
synapses are depressed with reduced spine area and depressed
mEPSC amplitude, whereas inhibitory synapses within the same
dendritic region display increased area and increasedmIPSC am-
plitude. Knockdown of cadherin-10 also leads to fewer PSD-95
clusters and lower overall abundance of PSD-95 in dendrites,
which may contribute to the E/I imbalance that we observe in
these neurons. Our data suggest that several simultaneous pro-
cesses may underlie the differential effects of cadherin-10 on
excitatory and inhibitory synapses. First, cadherin-10 interacts
differently with excitatory and inhibitory synapse stabilizing pro-
teins, with possibly divergent consequences on the two types of
synapses. Cadherin-10 interacts with PSD-95 and N-cadherin,
which in turn help to maintain excitatory synapse structure and
function. In contrast, at inhibitory synapses, cadherin-10 inter-
acts with gephyrin, potentially with less affinity than with PSD-
95, and does not complex with GABAARs or neuroligins. Thus,
the association of cadherin-10 with inhibitory synapses is likely
weaker and poorly suited to promote synapse stabilization. In
addition, we find higher expression of cadherin-10 at excitatory
compared with inhibitory synapses, which could explain a stron-
ger effect of cadherin-10 knockdown on excitatory synapses. In
support of our finding, recent mass spectrometry proteomics
reported a comparable distribution of cadherin-10 at excitatory
versus inhibitory synapses in themouse brain (excitatory, 26 pep-
tides; inhibitory, 12 peptides; Loh et al., 2016).
Second, the interaction between cadherin-10 andPSD-95may
be important in governing the distribution of neuroligins be-
tween excitatory and inhibitory synapses, thereby controlling the
E/I ratio. PSD-95 and cadherin-10 form complexes in cortex; this
fact, along with our finding of a correlation between the number
of cadherin-10 puncta and PSD-95 cluster dimensions, suggests
that cadherin-10 may help to maintain the integrity and stability
of PSD-95 clusters. PSD-95 is essential for maintaining synaptic
specificity of neuroligin isoforms and controlling the balance
between excitatory and inhibitory synapses within dendrites
(Shipman et al., 2011). Reduced PSD-95 expression levels cause a
redistribution of adhesion proteins from excitatory to inhibitory
synapses, thereby altering the E/I balance in the dendrite (Graf et
al., 2004; Prange et al., 2004; Levinson and El-Husseini, 2005;
Gerrow et al., 2006; Levinson et al., 2010). Consistent with this
model, our data suggest that cadherin-10 knockdown causes a re-
duction in overall PSD-95 expression, which could release other ex-
citatory synaptic components (such as neuroligins) and allow their
recruitment to inhibitory synapses within the same dendrite, thus
promoting a shift in the E/I balance toward inhibition (Fig. 7J).
Alternatively, cadherin-10 might exert a negative effect on synaptic
gephyrin, perhaps by sequestering gephyrin to perisynaptic sites
away from interactions with GABAARs at the center of the synapse.
On cadherin-10 knockdown this function would be relieved,
thereby allowing inhibitory synapses to become larger. Further in-
vestigation will be required to assess this possibility.
A correct balance of excitation and inhibition is required for
normal cortical function. Alterations in this balance in frontal
regions are thought to contribute to neuropsychiatric disorders,
including ASDs and schizophrenia (Gao and Penzes, 2015). Rare
point mutations in genes encoding several other synaptic adhe-
sion molecules, including neuroligins, neurexins, and other cad-
herins, have been detected in subjects with ASD (Betancur et al.,
2009). Studies of these proteins point to synaptic pathways that
can be disrupted in ASDs. However, since rare and highly pene-
trant mutations underlie only a small fraction of autism suscep-
tibility (1%), it is also important to study the functions of
common variants that likely work together to account for 50% of
autism susceptibility (Gaugler et al., 2014). Here we describe the
ASD common variant, cadherin-10, as a reciprocal regulator of
excitatory and inhibitory synapses. We show here for the first
4
(Figure legend continued.) projections of confocal z-stacks showing PSD-95 (red) in control and
cadherin-10 knock-downneurons. Scale bar, 5m. I, Total dendritic PSD-95 intensity and total
cluster density in control and knock-down neurons. Both the total dendritic PSD-95 intensity
and cluster density are reduced in knock-down neurons comparedwith control (total intensity:
416.9	 23.4 to 323	 16.3.3mean gray values, **p 0.004; density: 9.2	 1.2 to 6.4	 0.8
PSD-95 puncta/10m, *p 0.035, Mann–Whitney tests; n 10–11 neurons). J, Schematic
diagram summarizes the effects of cadherin-10 knockdown on excitatory and inhibitory syn-
apses. Cadherin-10 puncta aremore abundant at excitatory synapses than inhibitory synapses.
Cadherin-10 knockdown suppresses excitatory synaptic transmission and enhances inhibitory
synaptic transmission, leading to a decrease in the dendritic E/I ratio.
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time that a type II cadherin is localized to both excitatory and
inhibitory synapses and controls their efficacy in opposite direc-
tions. Our data suggest that cadherin-10 contributes to the regu-
lation of neuronal excitability in the cortex; dysregulation of this
pathway may contribute to an abnormal excitatory/inhibitory
balance that leads to psychiatric disorders.
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